Concord Asset Management (Virginia)’s Eli Lilly LLY Stock Holding History

Concord Asset Management (Virginia)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.72M	Sell	2,953 -249	-8%	-$252K	0.46%	57
2025 Q4	$3.44M	Sell	3,202 -46	-1%	-$44K	0.6%	38
2025 Q3	$2.48M	Sell	3,248 -404	-11%	-$301K	0.45%	57
2025 Q2	$2.85M	Buy	3,652 +614	+20%	+$477K	0.43%	54
2025 Q1	$2.52M	Sell	3,038 -1,879	-38%	-$1.56M	0.56%	46
2024 Q4	$3.8M	Buy	4,917 +377	+8%	+$312K	0.83%	31
2024 Q3	$4.02M	Buy	4,540 +485	+12%	+$436K	0.91%	34
2024 Q2	$3.67M	Buy	4,055 +597	+17%	+$478K	0.91%	28
2024 Q1	$2.69M	Buy	3,458 +590	+21%	+$420K	0.71%	39
2023 Q4	$1.67M	Buy	2,868 +1,228	+75%	+$717K	0.49%	45
2023 Q3	$881K	Buy	1,640 +258	+19%	+$133K	0.3%	57
2023 Q2	$648K	Buy	1,382 +174	+14%	+$73K	0.23%	56
2023 Q1	$415K	Buy	+1,208	New	+$407K	0.17%	66

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Concord Asset Management (Virginia)'s LLY Position: Q1 2026 in Review

Concord Asset Management (Virginia) reduced its Eli Lilly (LLY) stake by 7.8% in Q1 2026, selling an estimated $252K and leaving 2,953 shares worth $2.72M. The position accounts for 0.46% of the portfolio, ranked #57.

Concord Asset Management (Virginia) first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $4.02M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Concord Asset Management (Virginia) held 2,953 shares of Eli Lilly worth $2.72M as of Q1 2026.
Concord Asset Management (Virginia) sold 249 Eli Lilly shares in Q1 2026, an estimated $252K.
Eli Lilly made up 0.46% of Concord Asset Management (Virginia)'s portfolio in Q1 2026, its #57 holding.
Concord Asset Management (Virginia) first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
Concord Asset Management (Virginia)'s Eli Lilly position peaked at $4.02M in Q3 2024.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Concord Asset Management (Virginia)'s 13F filing for Q1 2026, filed 1 May 2026.